| No infection N = 475 (98.1%) | Infection N = 9 (1.9%) | All N = 484 | P value |
---|---|---|---|---|
Demographics | ||||
 Age, mean ± SD, (range), years | 62.5 ± 9.0 (33–88) | 63.4 ± 6.5 (48–71) | 62.5 ± 9.0 (48–71) | 0.75 |
 Race, n (%) |  |  |  | 1.0 |
  White | 351 (73.9) | 8 (88.9) | 359 (74.2) |  |
  Black | 77 (16.2) | 1 (11.1) | 78 (16.1) |  |
  Hispanic | 27 (5.7) | 0 (0.0) | 27 (5.6) |  |
  Other | 20 (4.2) | 0 (0.0) | 20 (4.1) |  |
Clinical characteristics | ||||
 Biopsy result, n (%) |  |  |  | 0.609 |
  Negative | 241 (50.7) | 4 (44.4) | 245 (50.6) |  |
  Prostate cancer | 185 (38.9) | 5 (55.6) | 190 (39.3) |  |
  HGPIN | 49 (10.3) | 0 (0.0) | 49 (10.1) |  |
 History of urinary tract infection, n (%) |  |  |  | 0.029 |
  Yes | 50 (10.5) | 3 (33.3) | 53 (10.9) |  |
  No | 414 (87.2) | 5 (55.6) | 419 (86.6) |  |
  Unknown/missing | 11 (2.3) | 1 (11.1) | 12 (2.5) |  |
 History of urinary retention; n (%) |  |  |  | 0.511 |
  Yes | 38 (8.0) | 1 (11.1) | 39 (8.1) |  |
  No | 387 (81.5) | 8 (88.9) | 395 (81.6) |  |
  Unknown/missing | 50 (10.5) | 0 (0.0) | 50 (10.3) |  |
 FQ usage in prior 2 years, n (%) |  |  |  | 0.681 |
  Yes | 109 (22.9) | 3 (33.3) | 112 (23.1) |  |
  No | 254 (53.5) | 4 (44.4) | 258 (53.3) |  |
  Unknown/Missing | 112 (23.6) | 2 (22.2) | 114 (23.6) |  |
 Hospitalized in prior 1 year; n (%) |  |  |  | 0.388 |
  Yes | 44 (9.3) | 2 (22.2) | 46 (9.5) |  |
  No | 418 (88.0) | 7 (77.8) | 425 (87.8) |  |
  Unknown/missing | 13 (2.7) | 0 (0.0) | 13 (2.7) |  |
 Healthcare worker; n (%) |  |  |  | 0.710 |
  Yes | 16 (3.4) | 0 (0.0) | 16 (3.3) |  |
  No | 406 (85.5) | 9 (100.0) | 415 (85.7) |  |
  Unknown/missing | 53 (11.2) | 0 (0.0) | 53 (11.0) |  |
 Charlson comorbidity score; n (%) |  |  |  | 0.144 |
  0 | 387 (81.5) | 6 (66.7) | 393 (81.2) |  |
  1 | 16 (3.4) | 1 (11.1) | 17 (3.5) |  |
  2 | 35 (7.4) | 0 (0.0) | 35 (7.2) |  |
  3–16 | 37 (7.8) | 2 (22.2) | 39 (8.1) |  |